Clinical trial NCT02264782: PreView: The Preventive Video Education in Waiting Rooms Program
Official title: PreView: The Preventive Video Education in Waiting Rooms Program
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Health Status Unknown
Lead sponsor: University of California, San Francisco
Sponsor class: OTHER
Collaborators: name: National Cancer Institute (NCI)
First posted: 2014-10-15
Enrollment: 508
Sex: ALL
Minimum age (years): 50
Maximum age (years): 70
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: SCREENING

Brief summary: This clinical trial studies how well PreView, preventive video education, works in increasing rates of breast, cervical and colorectal cancer screening, improving participants' stage of change with respect to age appropriate cancer screening and increasing patient-provider discussions about prostate cancer screening.

Detailed description: PRIMARY OBJECTIVES:

I. To determine the extent to which PreView increases the likelihood that primary care patient participants will receive mammograms, pap tests, colon cancer tests or prostate specific antigen (PSA) testing discussions with primary care physicians compared with participants who receive usual care.

II. To determine the extent that PreView increases participants' readiness to be screened for breast cancer, cervical cancer or colorectal cancer (CRC) compared with usual care.

III. To determine the extent that PreView increases the likelihood that PSA testing will be discussed in primary care physician visits compared with usual care.

OUTLINE: Patients are randomized into 1 of 2 groups.

GROUP I: Patients complete PreView, the Video Doctor plus Provider Alert, over 45 minutes on an iPad in the waiting room before a doctor visit.

GROUP II: Patients watch a video about healthy lifestyles including information about exercise and healthy eating over 45 minutes on an iPad in the waiting room before a doctor visit.

Eligibility criteria: Inclusion Criteria:

* Without a history of cancer

Exclusion Criteria:

* With a history of cancer (for whom subsequent procedures would be surveillance and not screening)
* Individuals who do not speak English or Spanish (except for the testimonials)

Primary outcomes:
measure: Changing participants' readiness to be screened for breast, cervical and colorectal cancer
timeFrame: Up to 3 hours from pre-visit to post-visit interview.
measure: Increasing physician-patient discussions about PSA screening measured by chart review
timeFrame: Baseline up to 14 months
measure: Increasing rates of breast, cervical and colorectal cancer screening
timeFrame: From Baseline up to 14 months
Secondary outcomes:
Other outcomes:
Locations:
city: Concord
country: United States
facility: John Muir Medical Center-Concord Campus
state: California
city: San Francisco
country: United States
facility: UCSF Medical Center-Mount Zion
state: California
Study officials:
affiliation: UCSF Medical Center-Mount Zion
name: Judith Walsh
role: PRINCIPAL_INVESTIGATOR
References:
citation: Walsh J, Potter M, Salazar R, Ozer E, Gildengorin G, Dass N, Green L. PreView: a Randomized Trial of a Multi-site Intervention in Diverse Primary Care to Increase Rates of Age-Appropriate Cancer Screening. J Gen Intern Med. 2020 Feb;35(2):449-456. doi: 10.1007/s11606-019-05438-0. Epub 2019 Nov 14.